October 14, 2020
Individuals With Blood Group O Have Lower Risk for COVID-19
WEDNESDAY, Oct. 14, 2020 (HealthDay News) — Individuals with blood group O may have a reduced risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and COVID-19 patients with blood group A or AB are at increased risk for requiring mechanical ventilation, according to two studies published online Oct. 14 in Blood Advances. Mike...
Surgeon General Issues Call to Action for Hypertension Control
WEDNESDAY, Oct. 14, 2020 (HealthDay News) — The path toward hypertension control includes making it a national priority, ensuring community support, and optimizing patient care, according to a call to action from the U.S. Surgeon General, summarized in an article published online Oct. 7 in the Journal of the American Medical Association. Jerome M. Adams,...
Immune Responses Long-Lasting After Serious COVID-19
WEDNESDAY, Oct. 14, 2020 (HealthDay News) — Protective antibodies persist for months in patients who survive serious COVID-19 infections, according to a study published Oct. 8 in Science Immunology. Anita S. Iyer, from Massachusetts General Hospital in Boston, and colleagues measured plasma and/or serum antibody responses to the receptor-binding domain (RBD) of the spike protein...
COVID-19 Antibody Treatment Study Paused
WEDNESDAY, Oct. 14, 2020 (HealthDay News) — Enrollment in a study testing an experimental antibody therapy against COVID-19 has been paused by independent monitors. The study, ACTIV-3, was testing the use of a single antibody with the antiviral drug remdesivir. The antibody is being developed by Eli Lilly and the Canadian company AbCellera, the Associated...
Black Race Tied to COVID-19 Admissions, but Not Deaths
WEDNESDAY, Oct. 14, 2020 (HealthDay News) — Black and Mixed/Other ethnicity are independently associated with greater hospital admission risk due to COVID-19 but are not associated with in-hospital mortality risk, according to a U.K. study published online Oct. 9 in EClinicalMedicine. Rosita Zakeri, from King’s College London in the United Kingdom, and colleagues examined whether...
Lack of Knowledge Barrier to Prone Positioning Use in ARDS
WEDNESDAY, Oct. 14, 2020 (HealthDay News) — Lack of knowledge is one of the barriers to use of prone positioning for acute respiratory distress syndrome (ARDS), a feature of severe COVID-19, according to a study published online Oct. 9 in the Annals of the American Thoracic Society. Tamar Klaiman, Ph.D., M.P.H., from the University of...
Sitagliptin May Cut Mortality in T2DM Patients With COVID-19
WEDNESDAY, Oct. 14, 2020 (HealthDay News) — Sitagliptin treatment added to standard care is associated with reduced mortality and improved clinical outcomes for patients with type 2 diabetes hospitalized with COVID-19, according to a study published online Sept. 29 in Diabetes Care. Sebastiano Bruno Solerte, from the University of Pavia in Italy, and colleagues conducted...
NIH Launches Trial of Antibody Drugs Against COVID-19
WEDNESDAY, Oct. 14, 2020 (HealthDay News) — A study to assess whether certain approved or experimental drugs are effective against COVID-19 and warrant testing in large clinical trials has been launched by the U.S. National Institutes of Health (NIH). The research will largely focus on monoclonal antibody medications. These types of drugs garnered headlines last...
Telehealth Disparity Seen in Cancer Care
WEDNESDAY, Oct. 14, 2020 (HealthDay News) — Black and Hispanic patients with cancer used telehealth less often than White patients during the COVID-19 pandemic in New York City, according to a study presented at the ASCO Quality Care Symposium, held virtually from Oct. 9 to 10. Cardinale B. Smith, M.D., Ph.D., and Aarti Sonia Bhardwaj,...